Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Robert Sheldon Added: 5 years ago
ProfessorRobert S. Sheldon discusses arandomized pragmatic trial of strategies of permanent pacemaker versus implantable cardiac monitor in older patients with syncope and bifascicular block. Filmed by Radcliffe Cardiology on-site at HRS 2018 in Boston, US. View more
Author(s): Tobias Reichlin Added: 7 months ago
ESC 2023 — Dr Tobias Reichlin (Inselspital, University of Bern, CH) joins us on-site at ESC 2023 to discuss the findings of the COMPARE-CRYO Trial (NCT04704986). The COMPARE-CRYO trial (Insel Gruppe AG, University Hospital Bern) aimed to compare the safety and efficacy of the PolarX Cryoballoon (Boston Scientific) with the Arctic Front Cryoballoon (Medtronic) in patients with symptomatic… View more
Author(s): Jason G Andrade , Atul Verma , Laurent Macle , et al Added: 3 years ago
AF is a common chronic, progressive disease, characterised by exacerbations and remissions. Over the past 10–15 years, multiple large-scale observational studies and randomised controlled trials have demonstrated that catheter ablation is superior to anti-arrhythmic drug (AAD) therapy in maintaining sinus rhythm and improving AF-related symptoms, exercise capacity and quality of life.1–7 The… View more
Author(s): Thorsten Lewalter , Giuseppe Boriani Added: 3 years ago
The monitoring of atrial fibrillation (AF) can be performed using a great variety of strategies and tools. Strategies range from monitoring only symptomatic AF (e.g., post-catheter ablation with or without surface electrocardiogram [ECG] documentation) to continuously monitoring heart rhythm using implantable pacemakers, implantable cardioverter defibrillators (ICDs) or subcutaneous implantable… View more
Author(s): Alessio Galli , Francesco Ambrosini , Federico Lombardi Added: 3 years ago
Since the 1960s, Holter monitoring has been a cornerstone for diagnosing suspected arrhythmias in patients of all ages.1 The most common monitoring systems allow the continuous registration of three or more leads for 24–48 hours; newer Holter monitors allow continuous electrocardiogram (ECG) registration for 2 weeks.1 Extending the time of ECG registration will increase the diagnostic yield of… View more
Author(s): A John Camm Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2 % of the general population and is increasingly prevalent in older people, occurring in about 10 % of over 80 year olds.1 AF is associated with a variety of cardiovascular conditions. The arrhythmia is associated with a five-fold rise in stroke risk and frequently coexists with heart failure, both leading… View more
Author(s): Konstantinos D Rizas , Wolfgang Hamm , Stefan Kääb , et al Added: 3 years ago
Experimental and clinical studies have demonstrated that enhanced sympathetic autonomic nervous system (SANS) activity can destabilise myocardial repolarisation,1–4 increasing vulnerability to developing fatal cardiac arrhythmias.5–8 Accordingly, assessment of SANS activity has always been a major goal for cardiac risk stratification methods. Various non-invasive methods including assessment of… View more
Author(s): Rahul G Muthalaly , Robert M Evans Added: 3 years ago
Artificial intelligence (AI) has recently become a popular term in the technological world. AI refers to the simulation of human intelligence with the capacity for achieving goals within computers. Machine learning (ML) – a subtype of AI – refers to a statistical model that is able to independently learn to make inferences on new data based on data it has previously analysed. ML has markedly… View more
Author(s): Justine Bhar-Amato , William Davies , Sharad Agarwal Added: 3 years ago
Ventricular tachyarrhythmias (VAs) most commonly occur early in ischaemia, and patients presenting with an acute MI and ventricular arrhythmias are a group that has a significantly increased risk of mortality.1,2 Thrombolysis primary percutaneous coronary intervention (PCI) and use of beta-blockers, while resulting in the modification of the natural history of an infarct, have also reduced the… View more